Farmacia
Facultad
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (147)
2024
-
3D-printed Laponite/Alginate hydrogel-based suppositories for versatile drug loading and release
Drug Delivery and Translational Research
-
Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury
Redox Biology, Vol. 71
2023
-
Akkermansia deficiency and mucin depletion are implicated in intestinal barrier dysfunction as earlier event in the development of inflammation in interleukin-10-deficient mice
Frontiers in Microbiology, Vol. 13
-
Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors
European Journal of Hospital Pharmacy
-
Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice
Antibiotics, Vol. 12, Núm. 3
-
Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms
Journal of clinical microbiology, Vol. 61, Núm. 4, pp. e0104922
-
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents
Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 7, pp. 2855-2882
-
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)
Frontiers in Pharmacology
-
Cost analysis of disease including treatment with dalbavancin in a Spanish hospital: ECODAL ANALYSIS
Journal of medical economics, Vol. 26, Núm. 1, pp. 463-472
-
Dietary Supplementation with a Cocoa–Carob Blend Modulates Gut Microbiota and Prevents Intestinal Oxidative Stress and Barrier Dysfunction in Zucker Diabetic Rats
Antioxidants, Vol. 12, Núm. 8
-
Evaluation of Anti-Neuroinflammatory Activity of Isatin Derivatives in Activated Microglia
Molecules, Vol. 28, Núm. 12
-
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 360-370
-
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
Frontiers in Pharmacology, Vol. 14
-
Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy
Frontiers in Oncology, Vol. 13
-
Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives
Journal of Personalized Medicine, Vol. 13, Núm. 3
-
Positron Emission Tomography-Computed Tomography and Magnetic Resonance Imaging Assessments in a Mouse Model of Implant-Related Bone and Joint Staphylococcus aureus Infection
Microbiology spectrum, Vol. 11, Núm. 3, pp. e0454022
-
Possible heart failure caused by osimertinib in a lung cancer patient
Journal of Oncology Pharmacy Practice, Vol. 29, Núm. 4, pp. 1015-1020
-
Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
Open Forum Infectious Diseases, Vol. 10, Núm. 2
-
Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study
Pharmacological Reports, Vol. 75, Núm. 5, pp. 1254-1264
-
Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function
Pharmacological Research, Vol. 189